Jagsonpal Pharmaceuticals to Acquire Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores
Jagsonpal Pharmaceuticals Ltd · Others (Uncategorized) · 23 Sept 2026, 11:22 pm
Jagsonpal Pharmaceuticals to Acquire Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores Jagsonpal Pharmaceuticals signed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via a slump sale on a going-concern basis. The target portfolio generated ₹24.6 crore in FY26 turnover. Total consideration is capped at ₹46.7 crore, comprising an upfront cash payment of ₹23.7 crore at closing and up to ₹23.0 crore in performance-linked earnouts tied to FY28 sales. The deal expands Jagsonpal’s footprint in women’s healthcare and is expected to close on or before 1st Nov'26.
Original exchange filing (PDF)
More announcements from Jagsonpal Pharmaceuticals Ltd
- Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.M · 03 Nov 2026
- Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M. · 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter September 30, 2026 · 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter ended September 30, 2026. · 29 Oct 2026
- Unaudited Financial Results (Standalone & Consolidated for the quarter and half year ended September 30, 2026. · 28 Oct 2026
- Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 28 Oct 2026
- Outcome of Board Meeting held on October 28, 2026 along with Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2026 · 28 Oct 2026
- JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 28 Oct 2026
